|
(2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide
|
|
1354546-42-1
|
|
(E/Z)-Trelnarizine Hydrochloride
|
|
99661-27-5
|
|
(2R,βR)-GC376
|
|
|
|
(±)16-HETE
|
|
128914-46-5
|
|
(E)-[6]-Dehydroparadol
|
|
878006-06-5
|
|
(±)8(9)-EET
|
|
|
|
(±)-Huperzine A
|
|
120786-18-7
|
|
(Ala1)-PAR4 (1-6) (mouse) trifluoroacetate salt
|
|
|
|
(2S,3S)-E1R
|
|
1424832-57-4
|
|
(Lys8,Lys9)-Neurotensin (8-13)
|
|
139026-64-5
|
|
(R)-(+)-Tolterodine
|
|
124937-51-5
|
|
(R)-5-Hydroxymethyl tolterodine
|
|
207679-81-0
|
|
(E)-4-Hydroxy-N-desmethyl tamoxifen
|
|
114828-90-9
|
|
(1E)-CFI-400437 dihydrochloride
|
|
1247000-76-5
|
|
(±)-Fabesetron hydrochloride
|
|
129299-81-6
|
|
(E)-Nitrofural
|
|
112574-44-4
|
|
(E/Z)-IT-603
|
|
292168-90-2
|
|
(24S)-24,25-Dihydroxyvitamin D3
|
|
55700-58-8
|
|
(±)9-HpODE
|
|
5502-91-0
|
|
(±)11(12)-EET
|
|
123931-40-8
|
|
(±)5(6)-EET Ethanolamide
|
|
|
|
(R)-(-)-Rolipram
|
|
85416-75-7
|
|
(2S,3R)-Voruciclib hydrochloride
|
|
|
|
(E)-4-Hydroxytamoxifen
|
|
174592-47-3
|
|
(2S)-2-Hydroxyglutaric acid
|
|
13095-48-2
|
|
(±)-Niguldipine hydrochloride
|
|
119934-51-9
|
|
(R)-6-Hydroxybuspirone
|
|
477930-30-6
|
|
(E/Z)-BCI
|
|
15982-84-0
|
|
(±)-Epibatidine
|
|
148152-66-3
|
|
(±)17(18)-EpETE
|
|
|
|
(R)-5-Methoxy-N-propyl-2-aminotetraline hydrochloride
|
|
93601-85-5
|
|
(7R)-3-Bromo-2,5-dimethoxybicyclo[4.2.0]octa-1,3,5-triene-7-methanamine
|
|
912440-88-1
|
|
(±)-Salsolinol hydrochloride
|
|
79923-51-6
|
|
(R)-(-)-Niguldipine Hydrochloride
|
|
113145-70-3
|
|
(2R,3S)-E1R
|
|
1424832-60-9
|
|
(1α,1'S,4β)-Lanabecestat
|
|
1384082-96-5
|
|
(2R)-TAPI-1
|
|
163847-77-6
|
|
(25S)-Δ7-Dafachronic acid
|
|
949004-12-0
|
|
(±)-Nipecotic acid
|
|
60252-41-7
|
|
(5Z,2E)-CU-3
|
|
1815598-71-0
|
|
(2Z)-LFM-A13
|
|
244240-24-2
|
|
(±)-BI-D
|
|
1416258-16-6
|
|
(±)-Evodiamine
|
|
518-18-3
|
|
(1S,3S)-ACPD
|
|
111900-31-3
|
|
(+)-U-50488 mesylate
|
|
107902-84-1
|
|
(2S,3R)-Voruciclib
|
|
1253731-24-6
|
|
(beta)-Estradiol 17-acetate
|
|
1743-60-8
|
|
(E)-GABAB receptor antagonist 1
|
|
1611483-29-4
|
|
(±)-Amiflamine
|
|
77502-96-6
|
|
(2S)-2-[(6,8-Difluoro-1,2,3,4-tetrahydro-2-naphthalenyl)amino]-N-[1-[2-[(2,2-dimethylpropyl)amino]-1,1-dimethylethyl]-1H-imidazol-4-yl]pentanamide
|
|
865773-15-5
|
|
(E/Z)-GO289
|
|
694522-87-7
|
|
(2R/S)-6-PNG
|
|
68682-01-9
|
|
(±)-N-Methylduloxetine hydrochloride
|
|
916135-70-1
|
|
(R)-(+)-8-Hydroxy-DPAT
|
|
80300-09-0
|
|
(E/Z)-AG490
|
|
134036-52-5
|
|
(E/Z)-BIO-acetoxime
|
|
740841-15-0
|
|
(2-Chloropyridin-4-yl)methanamine hydrochloride
|
|
916210-98-5
|
|
(Ala1)-PAR4 (1-6) amide (mouse) trifluoroacetate salt
|
|
|
|
(E/Z)-Sivopixant
|
|
1640808-39-4
|
|
(1S)-6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]pyrido[2,3-d]pyrimidin-2(1H)-one
|
|
2296729-66-1
|
|
(±)-Equol
|
|
94105-90-5
|
|
(R)-(+)-Nor Verapamil Hydrochloride
|
|
123932-43-4
|
|
(E)-Tetrachlorvinphos
|
|
22350-76-1
|
|
(±)2-(14,15-Epoxyeicosatrienoyl) Glycerol
|
|
848667-56-1
|
|
(E)-PAC-1
|
|
1044929-62-5
|
|
(±)-Epibatidine dihydrochloride
|
|
162885-01-0
|
|
(+/-)-alpha-Lipoamide
|
|
940-69-2
|
|
(±)10(11)-EDP Ethanolamide
|
|
2123484-71-7
|
|
(10S)-Methyllycaconitine citrate
|
|
351344-10-0
|
|
(3R,4R)-A2-32-01
|
|
1359752-95-6
|
|
(+)-U 50488
|
|
67198-17-8
|
|
(±)8(9)-EET methyl ester
|
|
|
|
(2R,3R)-E1R
|
|
1400888-63-2
|
|
(1S,3R,5R)-PIM447 dihydrochloride
|
|
|
|
(E)-RPL-554
|
|
1884461-72-6
|
|
(R)-(-)-N-Desmethyl-PK 11195
|
|
157809-85-3
|
|
(E/Z)-GSK5182
|
|
2699724-40-6
|
|
(E)-5-((4-(((Carboxymethyl)amino)carbonyl)phenyl)azo)-2-hydroxybenzoic acid
|
|
80573-03-1
|
|
(5S,8R)-HBV-IN-10
|
|
2716907-15-0
|
|
(±)17-HETE
|
|
128914-47-6
|
|
(2R,3'R)-Glycopyrrolate Bromide
|
|
475468-09-8
|
|
(±)-AMG 487
|
|
947536-03-0
|
|
(Glp1)-Apelin-13 trifluoroacetate salt
|
|
|
|
(±)5-HETE lactone
|
|
73279-37-5
|
|
(3S,5S)-Atorvastatin sodium salt
|
|
1428118-38-0
|
|
(R)-3-Hydroxy Midostaurin
|
|
155848-20-7
|
|
(±)17(18)-EpETE-Ethanolamide
|
|
2123491-23-4
|
|
(E)-Akt inhibitor-IV
|
|
959841-49-7
|
|
(±)-5'-Chloro-5'-deoxy-ENBA
|
|
103626-26-2
|
|
(±)5(6)-DiHET
|
|
213382-49-1
|
|
(D)-PPA 1
|
|
1620813-53-7
|
|
(2R,βS)-GC376
|
|
|
|
(E)-SIS3
|
|
521985-36-4
|
|
(2R,5S)-Ritlecitinib
|
|
1792180-79-0
|
|
(9R,10R)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene
|
|
|
|
(Hyp3)-Bradykinin acetate
|
|
|
|
(32-Carbonyl)-RMC-5552
|
|
2382768-55-8
|
|
(E/Z)-GSK-3β inhibitor 1
|
|
3367-88-2
|
|
(2S)-OMPT (ammonium salt)
|
|
645408-61-3
|
|
(E)-3,4-Dihydroxybenzylideneacetone
|
|
123694-03-1
|